Vertex Pharmaceuticals
$220.439876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$220.43
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$2.82 (-1.26%) As of 12:59 PM EST today
-$2.82 (-1.26%) Today
Why Robinhood?
You can buy or sell VRTX and other stocks, options, ETFs, and crypto commission-free!
About VRTX
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. Read More The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
Employees
2,500
Headquarters
Boston, Massachusetts
Founded
1989
Market Cap
57.36B
Price-Earnings Ratio
27.06
Dividend Yield
0.00
Average Volume
1.06M
High Today
$225.66
Low Today
$219.32
Open Price
$222.99
Volume
793.12K
52 Week High
$225.66
52 Week Low
$151.80
Collections
Analyst Ratings
77%
of 26 ratings
Buy
77%
Hold
19%
Sell
4%
VRTX Earnings
$0.62
$0.85
$1.07
$1.30
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Expected Feb 4, After Hours